Steroid Contraceptive Use and Cervical Dysplasia: Increased Risk of Progression
- 24 June 1977
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 196 (4297), 1460-1462
- https://doi.org/10.1126/science.867043
Abstract
In a prospective study of women with dysplasia of the cervix, there was an increase in severity of dysplasia and of conversion to cancer in situ in users of the contraceptive pill compared with users of other contraceptive methods. There was a delay in this adverse response. Nonreversal of dysplasia within the first 6 months of pill use is predictive of progression after prolonged exposure.This publication has 11 references indexed in Scilit:
- Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situAmerican Journal of Obstetrics and Gynecology, 1976
- Specific estrogen binding proteins in human cervixJournal of Steroid Biochemistry, 1975
- Early incidence rates of precancerous cervical lesions in women using contraceptivesGynecologic Oncology, 1973
- Contraceptive choice and dysplasia: Changes following the 1970 senate hearingsContraception, 1973
- A CASE CONTROL STUDY INTO THE POSSIBLE EFFECTS OF BIRTH CONTROL PILLS ON PRE‐CLINICAL CARCINOMA OF THE CERVIXBJOG: An International Journal of Obstetrics and Gynaecology, 1972
- Contraceptives and Dysplasia: Higher Rate for Pill ChoosersScience, 1970
- Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral SteroidsBMJ, 1969
- Epidemiological problems associated with studies of the safety of oral contraceptivesJAMA, 1968
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958